This contrasts a study in pediatric T-ALL patients, which showed that BCL11b expression had no impact on OS [[30]], although the difference may be due to the smaller sample size of the study and that patients were not classified into immunophenotypic subgroups. Here, BCL11B is linked to acute lymphoblastic leukemia.